A TERRA-NONO axis drives fibroblast reprogramming in cancer
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
Here, we identify a clinically relevant, telomere-associated nuclear pathway driving CAF activation across multiple human cancers.
Appeared: Sunday, October 4. Science Advances. Peer-reviewed journal.